Ocular Therapeutix
OCUL
#3713
Rank
ยฃ2.56 B
Marketcap
ยฃ12.04
Share price
27.54%
Change (1 day)
64.20%
Change (1 year)

Revenue for Ocular Therapeutix (OCUL)

Revenue in 2025 (TTM): ยฃ42.51 Million

According to Ocular Therapeutix's latest financial reports the company's current revenue (TTM ) is ยฃ41.86 Million. In 2024 the company made a revenue of ยฃ50.77 Million an increase over the revenue in the year 2023 that were of ยฃ45.87 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ocular Therapeutix from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ42.51 M-16.28%
2024 ยฃ50.77 M10.69%
2023 ยฃ45.87 M7.78%
2022 ยฃ42.56 M32.01%
2021 ยฃ32.24 M152.53%
2020 ยฃ12.76 M296.08%
2019 ยฃ3.22 M105.62%
2018 ยฃ1.56 M10.18%
2017 ยฃ1.42 M-6.96%
2016 ยฃ1.52 M29.5%
2015 ยฃ1.18 M138.15%
2014 ยฃ0.49 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Intersect ENT
XENT
ยฃ80.11 M 91.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
ยฃ60.72 M 45.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
ยฃ0.99 B 2,280.38%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
ยฃ90.66 M 116.56%๐Ÿ‡บ๐Ÿ‡ธ USA